Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Kenderick Lee was 24 and carving out a successful career in the corporate world when a diagnosis of the skin disease ...

Investigators aimed to highlight aspects that may predict the time to relapse among patients with psoriasis who discontinued use of biologic therapy.

Eligibility criteria were: (1) RCTs, single-arm trials and observational studies involving patients with GPP; (2) studies involving biologics for GPP; (3) studies reporting Generalized Pustular ...

Based on the immunopathology of psoriasis, we have proposed a model for biologic therapeutic approaches that identifies four mechanistic strategies. [25] A host of targeted immunologic ...

However, the shelf life after reconstitution varies with the biologic. Efalizumab can be ... Areas with bruising, redness, open sores, or psoriasis plaques should be avoided.

Treatment persistence varied by biologic therapy use, sex, and diagnostic codes among patients with psoriasis.